Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Gases firm Linde boosted by healthcare, ramps up oxygen production

Stock MarketsMay 06, 2021 12:15PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. FILE PHOTO: Men park Linde tankers after they arrived from abroad to help with coronavirus disease (COVID-19) crisis, at Netaji Subhas Chandra Bose International Airport (NSCBIA) in Kolkata, India, May 2, 2021. REUTERS/Rupak De Chowdhuri 2/2

By Sarah Morland and Veronica Snoj

(Reuters) -Linde, the world's largest industrial gases company, hiked its 2021 earnings outlook on Thursday, as a strong performance in its healthcare business helped it beat first quarter forecasts.

The U.S.-German company, which supplies gases such as oxygen, nitrogen and hydrogen to factories and hospitals, now expects adjusted earnings per share to rise 17-19% year-on-year - compared with its previous forecast for 11-13% growth.

Higher prices and growing demand in the healthcare sector - where Linde (NYSE:LIN) supplies equipment and medical gases including oxygen for COVID-19 patients - helped its sales in Europe, the Middle East and Africa jump 10% in the first quarter.

The pandemic has driven up demand for medical oxygen, particularly in India, where severe shortages and logistics problems have seen dozens of hospitals run short in recent weeks.

Chief Operating Officer Sanjiv Lamba said that teams in India were now producing more than 3,000 tonnes of medical oxygen daily, nearly ten-fold the figure four weeks ago.

"We've deployed about 1,200 drivers on the road, serving about 1,000 hospitals in the country," he added.

Linde, India's biggest oxygen producer, and other suppliers are ramping up production to more than 9,000 tonnes per day by mid-May, an executive told Reuters last week.

Lamba noted similar challenges in Mexico, Brazil and other Latin American countries - where infections continue to spread, filling up intensive care units, even as restrictions ease.

Linde's overall earnings per share for January-March rose 32% to $2.49, beating analysts' average estimate of $2.26 and its own guidance.

Linde's biggest competitor, Air Liquide (OTC:AIQUY), also beat analysts' forecasts last month, driven by strong demand for medical oxygen and an industrial rebound in China.

Gases firm Linde boosted by healthcare, ramps up oxygen production
 

Related Articles

These 3 Chip Stocks Are Cheap and Screaming Buy
These 3 Chip Stocks Are Cheap and Screaming Buy By StockNews - Jun 24, 2021

A global semiconductor chip supply crunch has resulted in rising capital investments in the semiconductor industry, given its applications in virtually every industry....

3 Overlooked Mortgage REITs With Yields Over 5%
3 Overlooked Mortgage REITs With Yields Over 5% By StockNews - Jun 24, 2021

There are many indicators that the economy could be due for a period of deceleration. This would be bullish for yield-payers like REIT stocks. Three REITs with attractive yields...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email